What Is Silica Aerogel? Structure, Thermal Performance and Insulation Applications

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: What Is Tridymite? Structure, Formation and Properties of This Silica Polymorph
  • Keywords: low CTE filler
  • Published: 2026-11-20 05:41:50
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
80. Ajit J. Nanoparticles in Drug Delivery. Prem. J. Sci. 2025;1:100048. doi: 10.70389/PJS.100048. [ DOI ] [ Google Scholar ]

Silicon Dioxide in Supplements: Purpose, Safety and Dosage Limits

1250 Mesh Silica: Particle Size, Specifications and Common Applications
In the case of melt granulation, it is necessary to use meltable excipients that can melt at low temperatures (50-90 °C) as a binder [ 98, 108 ]. The molten binder forms the agglomerates during cooling and solidification. Since it does not need a liquid binder, it is advantageous for use in the case of moisture-sensitive molecules. However, its use should be avoided for heat-sensitive materials.
Silica for LED Encapsulant: Optical Clarity, Purity and Grade Selection
Scratch Resistant Silica: How It Improves Coating Hardness and Durability
How to Choose a Silica Supplier: Key Criteria, Certifications and Red Flags
27. Argyo C., Weiss V., Bräuchle C., Bein T. Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery. Chem. Mater. 2014;26:435-451. doi: 10.1021/cm402592t. [ DOI ] [ Google Scholar ]

Silica as an Abrasive: Hardness, Particle Size and Applications

What is silica (SiO₂)?

Aerosil R972 To combat degradation and recrystallization, strategies such as surface functionalization with hydrophobic silanes, pore filling with polymeric co-formers, and selection of solvent-free loading methods (e.g., co-milling or melting) have been demonstrated to counteract water adsorption, increase drug-matrix interactions, and avoid solvent-templated polymorph formation. Tuning of pore size, surface chemistry, and loading processes allows MSNs to enable better long-term amorphous API stability and regulated polymorphism, thereby facilitating enhanced performance of nanoparticulate drug delivery systems.

What is the difference between fumed silica and precipitated silica?

fumed silica alternative

What drives silica raw material prices?

hollow glass microspheres Wet granulation is the most frequently used technique to process MSNs, because of the many possibilities inherent in it [ 106 ]. Conventional wet granulation is well-suited for the granulation of silica nanocarriers, but several things should be considered during implementation. There are two possible sequences: first, the drug loading, followed by the granulation of the loaded carriers [ 104 ], or the opposite way, the granulation of the empty carriers, then loading the drug into the prepared granules. In the first case, during the planning and implementation of the process, special attention must be paid to the critical process parameters to steer clear of premature drug release [ 104 ]. In general, it can be noted that as little moisture as possible should be used during granulation, consequently decreasing the risk of premature drug release. Still, simultaneously, moisture adequate to produce the desired agglomeration must be made sure [ 104 ]. The risk of premature drug release depends to a certain extent on the chemical structure of the API and the carrier. Szewczyk and Prokopowicz developed doxycycline-loaded MSN pellets with prolonged release kinetics [ 40 ]. First, the drug was loaded into the pores, and then pellets were produced from the loaded mesoporous material with other excipients by wet extrusion and spheronization. For comparison, traditional doxycycline pellets were also prepared. This study demonstrated the importance of utilizing mesoporous carriers for the delayed or sustained release of water-soluble drugs. Pelletization was a successful method to reduce the initial burst release of doxycycline; twice the release time was observed compared to traditional pellets [ 40 ]. Szewczyk et al. developed another DDS loaded with an antibiotic compound (cefazolin) for the treatment of osteomyelitis [ 66 ]. The amine-functionalized MSN was successfully loaded with the drug, and because of the powerful interactions between the negatively charged cefazolin and the positively charged surface of the carrier, a prolonged release of 5 days was observed, which made sure a longer antibacterial influence than with classic pellets. This was proven by the microbiological activity assays of the pellets against S. aureus culture [ 66 ]. These results are promising in antibiotic or anticancer therapy, where therapeutic concentration is needed for a longer period [ 40, 66 ]. A comparable outcome was presented in another publication about metformin-containing MSN pellets with prolonged release kinetics [ 85 ]. After drug loading, pellets were formed with the mixture of the preloaded carriers and chitosan solution, and then the pellets were coated with five layers of chitosan. Since the stomach is not considered the best possible absorption surface for metformin, it is advisable to delay the release until conditions in the intestines are ideal for maximum bioavailability. Chitosan plays an important role in this formulation; it slows down and delays the metformin release and offers delayed and prolonged release kinetics, thereby preventing speedy blood level peaks after application [ 85 ]. On the contrary, Wang et al. published a post on MSN pellets filled with poorly water-soluble carbamazepine, and they observed better oral bioavailability compared to commercially available tablets based on in vivo analysis performed on dogs [ 86 ]. In vitro dissolution studies confirmed a raised dissolution rate compared to crystalline carbamazepine due to the amorphous state of the drug within the pores. This immediate-release pellet formulation allows for a reduction in the drug dose, sustaining the same clinical influence [ 86 ].

Cite this article: Silica Raw Materials News. "Fused Silica Powder: Purity, Particle Sizes, CTE and Electronic Applications ." Published 2026-11-20 05:41:50. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.